Foreword I -- Foreword II -- Preface -- Author index -- Abbreviations -- Part I: INTERFACE OF DERMATOLOGY AND PSYCHIATRY -- 1 Perspectives on management of pediatric dermatologie disorders -- 1.1 Introduction -- 1.2 Skin infections and infestations -- 1.2.1 Bacterial infections -- 1.2.2 Viral infections -- 1.3 HIV/AIDS -- 1.3.1 Non-infectious skin lesions -- 1.3.2 Bacterial infections in HIV -- 1.3.3 Viral infections in HIV -- 1.3.4 Fungal infections in HIV -- 1.3.5 Fungal infections -- 1.3.6 Topical antifungals -- 1.3.7 Infestations -- 1.4 Dermatitis -- 1.4.1 Irritant dermatitis -- 1.4.2 Dry-skin dermatitis -- 1.4.3 Seborrheic dermatitis -- 1.4.4 Allergic dermatitides -- 1.4.5 Idiopathic dermatitides -- 1.5 Hypersensitivity -- 1.5.1 Urticaria -- 1.5.2 Drug eruptions -- 1.6 Miscellaneous skin conditions -- 1.6.1 Acne vulgaris -- 1.6.2 Nevi -- 1.6.3 Papulosquamous disorders -- 1.6.4 Lichens -- 1.6.5 Psoriasis -- 1.7 Dermatologic manifestations of systematic disorders -- 1.7.1 Pruritus without rash -- 1.7.2 Inflammatory bowel disease (IBD) -- 1.7.3 Erythema nodosum -- 1.7.4 Pyoderma gangrenosum -- 1.7.5 Less common skin manifestations -- 1.7.6 Management -- 1.8 Collagen vascular disease -- 1.8.1 Lupus erythematosus (SLE) -- 1.8.2 Dermatomyositis -- 1.8.3 Juvenile idiopathic arthritis -- 1.8.4 Management -- 1.9 Endocrinologic disorders -- 1.9.1 Thyroid disorders -- 1.9.2 Diabetes mellitus -- 1.9.3 Adrenal disorders -- 1.9.4 Management -- 1.10 Hair and nails -- 1.10.1 Alopecia areata -- 1.10.2 Telogen effluvium -- 1.10.3 Androgenic alopecia -- 1.10.4 Trichotillomania -- 1.10.5 Traction alopecia -- 1.10.6 Hirsutism and hypertrichosis -- 1.10.7 Hair changes with systemic disease -- 1.10.8 Infection -- 1.10.9 Bacterial -- 1.10.10 Fungal -- 1.10.11 Onychodystrophy.

1.10.12 Nail changes with systemic and nutritional disorders -- 2 Psychoneuroimmunology and other interactions between skin and psyche -- 2.1 Introduction -- 2.1.1 History of psychodermatology -- 2.1.2 Classification of psychodermatologic disorders -- 2.1.3 Psychological perspective of skin -- 2.1.4 Skin, mind, and the embryological embrace -- 2.2 Psychoneuroimmunology -- 2.2.1 Neuroendocrine response to stress -- 2.2.2 Immune response and central nervous system -- 2.2.3 Immune response and peripheral nervous system -- 2.2.4 Immune response and skin disease -- 2.2.5 Immune response and psychiatric disease -- 2.3 Conclusion -- 3 A clinician's approach to psychocutaneous diseases in adolescents: Untying the Gordian knot -- 3.1 Introduction -- 3.1.1 History taking skills in adolescent patients -- 3.2 Interviewing the adolescent patient -- 3.2.1 Confidentiality -- 3.2.2 Parental confidentiality -- 3.2.3 Health questionnaires -- 3.2.4 Interview techniques -- 3.2.5 Active listening skills -- 3.3 Concepts of the physical examination -- 3.4 Successful management of the adolescent patient -- 3.4.1 Informed consent -- 3.4.2 Shared decision makings -- 3.4.3 Improving compliance -- 3.5 Conclusion -- 4 Quality of life issues in children and adolescents with dermatological conditions and their wider impact on the family and society -- 4.1 Introduction -- 4.2 Pediatric quality of life and its assessment -- 4.3 Skin disease and quality of life -- 4.3.1 Impact of skin diseases on children's quality of life -- 4.3.2 Quality of life assessment in children with dermatological conditions -- 4.3.3 Children's Dermatology Life Quality Index (CDLQI) -- 4.3.4 Infant's Dermatitis Quality of Life Index (IDQoL) -- 4.3.5 Impact of skin disease on the quality of life of adolescents.

4.4 Assessment of adolescents' quality of life in dermatology -- 4.4.1 Teenager's QoL questionnaire (T-QoL) -- 4.4.2 Skindex-Teen -- 4.4.3 Impact of skin disease on family quality of life: The "greater patient" concept -- 4.5 Assessment of family quality in dermatology -- 4.5.1 Family Dermatology Life Quality Index (FDLQI) -- 4.5.2 Dermatitis Family Impact questionnaire (DFI) -- 4.5.3 Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD) -- 4.5.4 Childhood Atopic Dermatitis Impact Scale (CADIS) -- 4.5.5 Psoriasis Family Index (PFI) -- 4.6 Societal impact of childhood dermatological conditions -- 4.7 Conclusions -- Part II: PSYCHOPHYSIOLOGIC DISORDERS -- 5 Atopic dermatitis: a psychocutaneous review -- 5.1 Introduction -- 5.1.1 Epidemiology -- 5.2 Pathophysiologic factors in atopic dermatitis -- 5.2.1 Genetic predisposition -- 5.2.2 Socio-economic status -- 5.2.3 Family size -- 5.2.4 Food allergens -- 5.3 Psychoneuroimmunologic factors -- 5.3.1 Breast feeding -- 5.3.2 Environmental allergens -- 5.4 Psychophysiological aspects of atopic dermatitis -- 5.4.1 Impact of stress on the immunological system -- 5.4.2 Psychoanalytic hypothesis -- 5.4.3 Biopsychosocial model -- 5.4.4 Psychological dysregulation due to atopic dermatitis -- 5.5 Clinical features -- 5.6 Diagnosis -- 5.6.1 Allergy Testing -- 5.6.2 Differential Diagnosis -- 5.7 Management -- 5.7.1 Prevention of relapse -- 5.7.2 Food allergens -- 5.7.3 Aeroallergens -- 5.7.4 Optimizing the epidermal barrier (EB) -- 5.7.5 Hydration therapy -- 5.7.6 Management of pruritus -- 5.7.7 Topical corticosteroids -- 5.7.8 Topical immunomodulators -- 5.8 Systematic treatment of atopic dermatits -- 5.8.1 Antihistamines -- 5.8.2 Phototherapy -- 5.8.3 Antibiotics -- 5.8.4 Systemic corticosteroids -- 5.8.5 Immunomodulators -- 5.8.6 Cyclosporine -- 5.8.7 Azathioprine.

5.8.8 Infliximab -- 5.8.9 Interferon-γ -- 5.8.10 Leukotriene inhibitors -- 5.9 Psychiatric comorbidities -- 5.9.1 Family dynamics -- 5.9.2 Internalizing and externalizing behaviors -- 5.9.3 Anxiety and depression -- 5.9.4 Personality traits -- 5.10 Management of psychiatric comorbidities -- 5.10.1 Multidisciplinary approach -- 5.10.2 Psychoeducation -- 5.10.3 Psychosocial assessment -- 5.10.4 Psychiatric symptoms review -- 5.10.5 Quality of life assessment -- 5.10.6 Psychodynamic therapy -- 5.10.7 Cognitive behavioral therapy -- 5.10.8 Behavioral modifications -- 5.10.9 Psychotropic medications -- 5.11 Conclusion -- 6 Psoriasis and children: A psychological approach -- 6.1 Introduction -- 6.1.1 Epidemiology -- 6.2 Dermatological clinical features -- 6.2.1 Plaque psoriasis -- 6.2.2 Guttate psoriasis -- 6.2.3 Erythrodermic psoriasis -- 6.2.4 Pustular psoriasis -- 6.2.5 Psoriatic arthritis -- 6.2.6 Inverse psoriasis -- 6.3 Psychological clinical features -- 6.3.1 Differential diagnosis -- 6.3.2 Psychotherapeutic intervention -- 6.3.3 Psychotherapy -- 6.4 Conclusions -- 7 The acnes: Acne vulgaris, acne rosacea, and acne excoriée -- 7.1 Acne Vulgaris -- 7.1.1 Introduction -- 7.1.2 Epidemiology -- 7.1.3 Pathogenesis -- 7.1.4 Classification -- 7.1.5 Management -- 7.1.6 Teratogenicity and isotretinoin -- 7.1.7 Depression, suicidality, and isotretinoin -- 7.2 Acne Rosacea -- 7.2.1 Pathophysiology -- 7.2.2 Management of acne rosacea -- 7.3 Acne Variants -- 7.4 Conclusion -- 8 Psychogenic purpura (Gardner-Diamond syndrome) -- 8.1 Introduction -- 8.2 History -- 8.3 Etiology and pathogenesis -- 8.4 Clinical features -- 8.5 Differential diagnosis -- 8.5.1 Disease course -- 8.5.2 Histopathology -- 8.5.3 Laboratory testings -- 8.5.4 Psychological disturbances -- 8.6 Treatment approaches and recommendations -- 8.7 Conclusion.

Part III: PSYCHIATRIC DISORDERS WITH DERMATOLOGIC MANIFESTATIONS -- 9 Body dysmorphic disorder in adolescents -- 9.1 Introduction -- 9.2 Definition -- 9.2.1 Epidemiology -- 9.2.2 Clinical features -- 9.2.3 Differential diagnosis -- 9.3 Management -- 9.3.1 Preliminary considerations -- 9.3.2 The clinical interview -- 9.3.3 Assessment -- 9.3.4 Patient education -- 9.3.5 Treatment -- 9.4 Other treatment techniques -- 9.4.1 Anxiety management training (AMT) -- 9.4.2 Eye movement desensitization and reprocessing (EMDR) -- 9.4.3 Family therapy -- 9.4.4 Group therapy -- 9.4.5 Metaphors -- 9.4.6 Mindfulness -- 9.4.7 Intervention -- 9.4.8 Nonpsychiatric medical treatment -- 9.4.9 Final management considerations -- 9.5 Conclusions -- 10 Delusional infestation in childhood, adolescence, and adulthood -- 10.1 Introduction -- 10.2 How to diagnose a delusion -- 10.3 Primary and secondary delusional infestation -- 10.4 The context of children and adolescence -- 10.5 Clinical pictures -- 10.5.1 Case one -- 10.5.2 Case two -- 10.5.3 Case Three -- 10.5.4 Commentary on these three cases -- 10.6 Delusional elaboration ("Wahnarbeit") -- 10.7 Prevalence of delusional infestation -- 10.7.1 Treatment -- 10.7.2 Which antipsychotic in DI? -- 10.8 Antipsychotics -- 10.9 Conclusion -- 11 Dermatitis artefacta, skin picking, and other self-injurious behaviors: A psychological perspective -- 11.1 Introduction -- 11.2 Epidemiology -- 11.3 Etiology -- 11.4 Clinical features -- 11.4.1 Dermatitis Artefacta -- 11.4.2 Skin picking -- 11.4.3 Self-mutilation behavior -- 11.5 Differential diagnosis -- 11.6 Management -- 11.6.1 Pharmacological Treatment -- 11.6.2 Psychotherapy -- 11.6.3 Issues with Treatment -- 11.7 Conclusions -- 12 Trichotillomania -- 12.1 Introduction -- 12.2 Definition -- 12.3 Differential diagnosis -- 12.4 Assessment -- 12.5 Management.

12.5.1 Psychotherapy.